[1]
“Subtype performance of the ancillary diagnostic 23- and 35-gene expression profile (GEP) tests for difficult-to-diagnose melanocytic lesions”, J of Skin, vol. 7, no. 3, p. s214, May 2023, doi: 10.25251/skin.7.supp.214.